EBR vs NTI

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

EBR

EBR SYSTEM CDI FORUS [EBR]

48LOW

NTI

NEUROTECH FPO [NTI]

48LOW

Score Breakdown

EBR NTI
Technical
63
47
Catalyst
50
66
Sentiment
50
50
Fundamental
66
70
Momentum
36
42
Risk Gate
46
31

Key Metrics

EBR Metric NTI
$322.1MMarket Cap$14.3M
429KAvg Volume (20d)826K
+0.0%Short InterestN/A
$2.08052-Week High$0.037
$0.64052-Week Low$0.010
+5.1%Daily Change+0.0%
$0.720Entry Price$0.011
-195.3%ROE-66.3%
N/AProfit Margin-54.4%

Active Signals

EBR Signals

●MACD momentum is picking up steam
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●4C filed 2026-03-18
●Very high P/S ratio (199.2x)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

NTI Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Lagging the Small Ords index — relative strength of 0.87, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Low P/S ratio (2.0x)
●Strong revenue growth (+4069%)

Ask Scout AI to compare EBR and NTI in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EBR Full Analysis → NTI Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).